Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

BACKGROUND AND AIMS: Non‐alcoholic steatohepatitis (NASH) is a chronic disease that can progress to end‐stage liver disease (ESLD). A large proportion of early‐stage NASH patients remain undiagnosed compared to those with advanced fibrosis, who are more likely to receive disease management intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Schattenberg, Jörn M., Lazarus, Jeffrey V., Newsome, Philip N., Serfaty, Lawrence, Aghemo, Alessio, Augustin, Salvador, Tsochatzis, Emmanuel, de Ledinghen, Victor, Bugianesi, Elisabetta, Romero‐Gomez, Manuel, Bantel, Heike, Ryder, Stephen D., Boursier, Jerome, Leroy, Vincent, Crespo, Javier, Castera, Laurent, Floros, Lefteris, Atella, Vincenzo, Mestre‐Ferrandiz, Jorge, Elliott, Rachel, Kautz, Achim, Morgan, Alice, Hartmanis, Sally, Vasudevan, Sharad, Pezzullo, Lynne, Trylesinski, Aldo, Cure, Sandrine, Higgins, Victoria, Ratziu, Vlad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Liver Disease and Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252761/
https://www.ncbi.nlm.nih.gov/pubmed/33590598
http://dx.doi.org/10.1111/liv.14825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252761/
https://www.ncbi.nlm.nih.gov/pubmed/33590598
http://dx.doi.org/10.1111/liv.14825

Ejemplares similares